A 24-week, randomized, parallel study evaluating efficacy of testosterone replacement therapy (TRT) on concomitant dutasteride in men with late-onset hypogonadism.

Trial Profile

A 24-week, randomized, parallel study evaluating efficacy of testosterone replacement therapy (TRT) on concomitant dutasteride in men with late-onset hypogonadism.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2016

At a glance

  • Drugs Dutasteride (Primary) ; Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top